SLS

SELLAS Life Sciences GroupD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

SLS vs peer average

30/100

SLS vs. peer average (D vs. C)

Grade spread

A 4 · B 2 · D 3 · F 2

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

ADMA is the first available peer comparator.

Same-sector, similar-market-cap candidate from the packet; useful only as broad biotech valuation and volatility context because no direct AML or program overlap is established.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerADMAADMA Biologics

SLS

SELLAS Life Sciences Group

ADMA

ADMA Biologics

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Defensive

Constructive

Open Side-by-Side Comparison Compare all

Grade position vs ADMA

SLS / ADMA

Grade Position

Below peers

SLS vs. peer average (D vs. C)

30/100

Momentum

SLS

Value

ADMA

Sentiment

ADMA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs SLS

ADMA

100/100

-3

BHVN

100/100

-3

MESO

40/100

Even

TRVI

Trevi Therapeutics Inc Common

20/100

VRDN

Viridian Therapeutics Inc Common

80/100

-2

ADMA is the first peer returned for this comparison set.